The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)
statement, published in 2009, was designed to help systematic reviewers transparently …
statement, published in 2009, was designed to help systematic reviewers transparently …
[HTML][HTML] Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment
A Hróbjartsson, PC Gøtzsche - New England Journal of Medicine, 2001 - Mass Medical Soc
Background Placebo treatments have been reported to help patients with many diseases,
but the quality of the evidence supporting this finding has not been rigorously evaluated …
but the quality of the evidence supporting this finding has not been rigorously evaluated …
Placebo interventions for all clinical conditions
A Hróbjartsson, PC Gøtzsche - Cochrane database of …, 2004 - cochranelibrary.com
Placebo interventions for all clinical conditions - Hróbjartsson, A - 2004 | Cochrane Library Skip
to Content Cookies Our site uses cookies to improve your experience. You can find out more …
to Content Cookies Our site uses cookies to improve your experience. You can find out more …
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Non-randomised studies of the effects of interventions are critical to many areas of
healthcare evaluation, but their results may be biased. It is therefore important to understand …
healthcare evaluation, but their results may be biased. It is therefore important to understand …
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews
The methods and results of systematic reviews should be reported in sufficient detail to allow
users to assess the trustworthiness and applicability of the review findings. The Preferred …
users to assess the trustworthiness and applicability of the review findings. The Preferred …
RoB 2: a revised tool for assessing risk of bias in randomised trials
Assessment of risk of bias is regarded as an essential component of a systematic review on
the effects of an intervention. The most commonly used tool for randomised trials is the …
the effects of an intervention. The most commonly used tool for randomised trials is the …
SPIRIT 2013 statement: defining standard protocol items for clinical trials
The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting,
and appraisal. However, trial protocols and existing protocol guidelines vary greatly in …
and appraisal. However, trial protocols and existing protocol guidelines vary greatly in …
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
High quality protocols facilitate proper conduct, reporting, and external review of clinical
trials. However, the completeness of trial protocols is often inadequate. To help improve the …
trials. However, the completeness of trial protocols is often inadequate. To help improve the …
Guidelines for reporting reliability and agreement studies (GRRAS) were proposed
Objective Results of reliability and agreement studies are intended to provide information
about the amount of error inherent in any diagnosis, score, or measurement. The level of …
about the amount of error inherent in any diagnosis, score, or measurement. The level of …
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles
ContextSelective reporting of outcomes within published studies based on the nature or
direction of their results has been widely suspected, but direct evidence of such bias is …
direction of their results has been widely suspected, but direct evidence of such bias is …